About the Transaction
Founded in 2010 with the intention of delivering a revolutionary tool to the healthcare market that discreetly and conveniently monitored alcohol addiction, Soberlink introduced a new approach to recovery with the launch of the first truly mobile handheld alcohol monitoring system, the SL2 (2012). An unobtrusive device that features facial recognition, the SL2’s cellular technology transmits breath alcohol tests directly from the SL2 Breathalyzer to a user-friendly, cloud-based monitoring web portal. The Company’s software as a service platform can be customized and scaled to specific client needs and its devices and software services are currently offered in all 50 states and Canada. This is the second corporate finance engagement Envisage executed for the Company. In April 2014, Envisage advised the Company in connection with raising growth capital.
Soberlink, Inc. (“Soberlink” or the “Company”) is a leading developer of remote alcohol monitoring products and services, including a software as a service platform.
Envisage advised Soberlink on (i) the sale of its Criminal Justice business division and (ii) a capital raise for its Healthcare business division.
- Company was subject to a number of structural challenges which made selling difficult
- Soberlink was organized in an inefficient manner from a tax perspective
- Envisage identified a number of debt sources willing to provide the Company growth capital with minimal equity dilution
- Envisage’s principals worked through several complexities and successfully structured and negotiated the transaction
Still Have Questions?
Please contact Leo Fernandez if you would like to discuss this transaction.